Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients

NCT01645787 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Spinal Muscular Atrophy

Interventions

DRUG: 4-aminopyridine
DRUG: Placebo

Sponsor

Columbia University

Collaborators

[object Object]